{"id":"https://openalex.org/W2104828754","doi":"https://doi.org/10.2174/1871520614666140829124925","title":"Organometallic Compounds in Cancer Therapy: Past Lessons and Future Directions","display_name":"Organometallic Compounds in Cancer Therapy: Past Lessons and Future Directions","publication_year":2014,"publication_date":"2014-08-29","ids":{"openalex":"https://openalex.org/W2104828754","doi":"https://doi.org/10.2174/1871520614666140829124925","mag":"2104828754","pmid":"https://pubmed.ncbi.nlm.nih.gov/25173559"},"language":"en","primary_location":{"id":"doi:10.2174/1871520614666140829124925","doi":"https://doi.org/10.2174/1871520614666140829124925","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871520614666140829124925","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115590972","display_name":"Pedro Henrique de Farias Martins","orcid":"https://orcid.org/0000-0002-7943-8093","observed_orcids":["https://orcid.org/0000-0002-7943-8093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Martins","raw_affiliation_strings":["DCV - Departamento de Ci\u00eancias da Vida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DCV - Departamento de Ci\u00eancias da Vida","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088658211","display_name":"Mara Marques","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mara Marques","raw_affiliation_strings":["DCV - Departamento de Ci\u00eancias da Vida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DCV - Departamento de Ci\u00eancias da Vida","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043087266","display_name":"Lidia Coito","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lidia Coito","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081571915","display_name":"Armando J. L. Pombeiro","orcid":"https://orcid.org/0000-0001-8323-888X","observed_orcids":["https://orcid.org/0000-0001-8323-888X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Armando Pombeiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007842415","display_name":"Pedro Viana Baptista","orcid":"https://orcid.org/0000-0001-5255-7095","observed_orcids":["https://orcid.org/0000-0001-5255-7095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Baptista","raw_affiliation_strings":["DCV - Departamento de Ci\u00eancias da Vida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DCV - Departamento de Ci\u00eancias da Vida","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026233373","display_name":"Alexandra Ramos Fernandes","orcid":"https://orcid.org/0000-0003-2054-4438","observed_orcids":["https://orcid.org/0000-0003-2054-4438"]},"institutions":[{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Alexandra Fernandes","raw_affiliation_strings":["Departamento de Ciencias da Vida, Faculdade de Ciencias e Tecnologia da Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal. ma.fernandes@fct.unl.pt","Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia da Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ciencias da Vida, Faculdade de Ciencias e Tecnologia da Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal. ma.fernandes@fct.unl.pt","institution_ids":["https://openalex.org/I83558840"]},{"raw_affiliation_string":"Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia da Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal","institution_ids":["https://openalex.org/I83558840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.621,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.90936255,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"14","issue":"9","first_page":"1199","last_page":"1212"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11746","display_name":"Inorganic and Organometallic Chemistry","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12458","display_name":"Organometallic Compounds Synthesis and Characterization","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/organometallic-compounds","display_name":"organometallic compounds","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/metal-based-anticancer-agents","display_name":"metal-based anticancer agents","score":0.8029999732971191},{"id":"https://openalex.org/keywords/homogeneous-catalysis","display_name":"homogeneous catalysis","score":0.7149999737739563},{"id":"https://openalex.org/keywords/ligand-exchange","display_name":"ligand exchange","score":0.8330000042915344},{"id":"https://openalex.org/keywords/redox-properties","display_name":"redox properties","score":0.9039999842643738},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6840000152587891},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.8579999804496765},{"id":"https://openalex.org/keywords/systemic-toxicity","display_name":"systemic toxicity","score":0.9890000224113464},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.9950000047683716},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.63820880651474},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5847001075744629},{"id":"https://openalex.org/C514695523","wikidata":"https://www.wikidata.org/wiki/Q237200","display_name":"Organometallic chemistry","level":3,"score":0.5301207900047302},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4848090708255768},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.455030232667923},{"id":"https://openalex.org/C91967747","wikidata":"https://www.wikidata.org/wiki/Q2770033","display_name":"Group 2 organometallic chemistry","level":3,"score":0.43039047718048096},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.4246116578578949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3883119523525238},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3500025272369385},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.2800511121749878},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2309322953224182},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1969071626663208},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1834602952003479},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.08360069990158081}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D053769","descriptor_name":"Nanocapsules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056831","descriptor_name":"Coordination Complexes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D056831","descriptor_name":"Coordination Complexes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1871520614666140829124925","doi":"https://doi.org/10.2174/1871520614666140829124925","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871520614666140829124925","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:25173559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25173559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W628260754","https://openalex.org/W2017356685","https://openalex.org/W2159733863"],"related_works":["https://openalex.org/W2992385243","https://openalex.org/W1963719070","https://openalex.org/W2064894863","https://openalex.org/W214223599","https://openalex.org/W7023672818","https://openalex.org/W4403324893","https://openalex.org/W2262260741","https://openalex.org/W2898615007","https://openalex.org/W4412644892","https://openalex.org/W4362523035"],"abstract_inverted_index":{"Over":[0,71],"the":[1,72,107],"past":[2],"few":[3,84],"years,":[4],"modern":[5],"medicinal":[6],"chemistry":[7],"has":[8,77],"evolved":[9],"towards":[10,21],"providing":[11],"us":[12],"new":[13],"and":[14,34,60,82,98,130,141],"alternative":[15],"chemotherapeutic":[16],"compounds":[17,33,86,112],"with":[18,25,115],"high":[19],"cytotoxicity":[20],"tumor":[22],"cells,":[23],"alongside":[24],"reduced":[26],"side":[27],"effects":[28],"in":[29,41,88,113],"cancer":[30,69,118],"patients.":[31],"Organometallic":[32],"their":[35,139],"unique":[36],"physic-chemical":[37],"properties":[38,62],"typically":[39],"used":[40],"homogenous":[42],"catalysis":[43],"are":[44,145],"now":[45],"being":[46],"translated":[47],"as":[48,120,122],"potential":[49],"candidates":[50,67],"for":[51,68],"medical":[52],"purposes.":[53],"Their":[54],"structural":[55],"diversity,":[56],"ligand":[57],"exchange,":[58],"redox":[59],"catalytic":[61],"make":[63],"them":[64],"promising":[65],"drug":[66],"therapy.":[70],"last":[73],"decade":[74],"this":[75],"area":[76],"witnessed":[78],"a":[79,83],"steady":[80],"growth":[81],"organometallic":[85,111],"have":[87],"fact":[89],"already":[90],"entered":[91],"clinical":[92,99],"trials,":[93],"emphasizing":[94],"its":[95],"increasing":[96],"importance":[97],"relevance.":[100],"Here":[101],"we":[102],"intend":[103],"to":[104],"stress":[105],"out":[106],"different":[108],"applications":[109],"of":[110],"medicine":[114],"emphasis":[116],"on":[117],"therapy,":[119],"well":[121],"address":[123],"setbacks":[124],"regarding":[125],"formulation":[126],"issues,":[127],"systemic":[128],"toxicity":[129],"off-target":[131],"effects.":[132],"Advantages":[133],"over":[134],"classical":[135],"coordination":[136],"metal":[137],"complexes,":[138],"nanovectorisation":[140],"specific":[142],"molecular":[143],"targets":[144],"also":[146],"discussed.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
